25 apr: Klassiske fejl når du investerer din pension - 1
30 apr: Kursfald oplagt købsmulighed i Novozymes
25-04-2012 14:00:00

Corning 1Q Net Down 38% On LCD Glass Weakness; Sees 2Q Improvement

Relateret indhold

DOW JONES NEWSWIRES

Corning Inc.'s (GLW) first-quarter profit fell 38% as sharply lower prices for its liquid-crystal-display glass continued to weaken results.

But shares were up 3.9% premarket at $13.87 as the company beat earnings and revenue expectations and it signaled improving pricing in LCD glass in the current quarter, as well as continued strength in its telecommunications segment. Through Tuesday's close, the stock is up 2.9% so far this year.

Corning, the world's largest maker of LCD glass for televisions, was hurt last year by lackluster TV demand, which has forced down prices for its display glass due to oversupply. The company responded in the fourth quarter by cutting capacity, hoping to restore some balance to pricing, but expected prices to remain depressed in the latest period. The display business accounts for more than a third of Corning's revenue and the vast bulk of its earnings.

Sterne Agee said this week that though Corning was expected to post significantly lower earnings in the first quarter, the company should benefit in future periods as glass gross margins could bottom in the second quarter and Corning continues to diversify into non-display segments.

"After two successive quarters of significant LCD glass price declines, we expect our price declines will be much more moderate this quarter," Corning Chief Financial Officer James B. Flaws said Wednesday.

As part of its diversification effort, Corning earlier this month unveiled plans to pay about $730 million in cash to acquire the bulk of Becton Dickinson & Co.'s (BDX) lab-products business, snapping up a portfolio it said will significantly increase its presence in the life-sciences market. The company also sees increased demand in its telecommunications business.

Corning posted a profit of $462 million, or 30 cents a share, down from $748 million, or 47 cents a share, a year earlier. Revenue edged down 0.2% to $1.92 billion.

Analysts surveyed by Thomson Reuters expected earnings of 28 cents a share on revenue of $1.87 billion.

Gross margin fell to 42.4% from 45.4%.

Display technology sales, the company's largest revenue driver, declined 11% to $705 million. Telecommunications sales were $508 million, up about 7%.

-By Ben Fox Rubin, Dow Jones Newswires; 212-416-3108; ben.rubin@dowjones.com

(END) Dow Jones Newswires

April 25, 2012 08:00 ET (12:00 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Harboes H1: Dårligt sommervejr ramte både omsætningen og indtjeningen

13-12-2017 15:48:19
Dårligt sommervejr i Nordeuropa ramte både omsætningen og indtjeningen hos Harboes Bryggeri, der har haft et markant dårligere første halvår af det skæve regnskabsår 2017/18 sammenlignet med for et år siden.Nettoomsætningen fra maj til udgangen af oktober faldt til 696,4 mio. kr. mod 744,6 mio. kr. i samme periode året forinden, fremgår det af halvårsregnskabet for 2017/18 onsdag eftermiddag.På de..

Novo-rival spår effekt af ugentligt GLP-1 på linje med Ozempics

13-12-2017 13:30:09
Novo Nordisks store franske rival Sanofi forudser, at dens ugentlige GLP-1-analog, Efpeglenatid, har en effekt på langtidsblodsukkeret, der er på linje Novos nye ugentlige diabetes 2-middel Ozempic, som tilhører samme lægemiddelklasse.Det fremgår af en præsentation under et analytikerarrangement onsdag, hvor Sanofi fremlægger sin forsknings- og udviklingsstrategi for de kommende år.Sanofi indledte..

Novo-rival er på vej med nye studier i fedme og leversygdommen NASH

13-12-2017 09:56:25
Novo Nordisks store franske rival, Sanofi, vil ligesom Novo i de kommende år også fokusere på udviklingen af fedmemedicin og medicin til behandling af leversygdommen, NASH.Det fremgår af en pressemeddelelse i forbindelse med et analytikerarrangement onsdag, hvor Sanofi vil præsentere sin forsknings- og udviklingsstrategi for de kommende år.Sanofis udviklingsindsats inden for forretningsområdet, di..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Vestas får sin største ordre nogensinde i Indien - NY
2
Vestas rykker nærmere kæmpekontrakter i New Mexico og Texas
3
Onsdagens aktier: Genmab endnu engang til bunds i negativt marked
4
Aktier: C20 og kompagni lagt ned i timevis af teknisk uheld - NY4
5
Nilfisk: Storaktionær opfordrer til fusion med konkurrent - NY2

Relaterede aktiekurser

Corning Incorporated 32,29 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2017  Disclaimer Privatlivspolitik
Aktieinformation leveres af Morningstar.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
14. december 2017 09:01:23
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20171124.1 - EUROWEB7 - 2017-12-14 09:01:23 - 2017-12-14 09:01:23 - 1 - Website: OKAY